New strategy to attack aggressive brain cancer shows promise
Time:2024-05-21 22:13:09 Source:politicsViews(143)
WASHINGTON (AP) — A new strategy to fight an extremely aggressive type of brain tumor showed promise in a pair of experiments with a handful of patients.
Scientists took patients’ own immune cells and turned them into “living drugs” able to recognize and attack glioblastoma. In the first-step tests, those cells shrank tumors at least temporarily, researchers reported Wednesday.
So-called CAR-T therapy already is used to fight blood-related cancers like leukemia but researchers have struggled to make it work for solid tumors. Now separate teams at Massachusetts General Hospital and the University of Pennsylvania are developing next-generation CAR-T versions designed to get past some of glioblastoma’s defenses.
“It’s very early days,” cautioned Penn’s Dr. Stephen Bagley, who led one of the studies. But “we’re optimistic that we’ve got something to build on here, a real foundation.”
Previous:Yu Darvish extends scoreless innings streak to 25 in Padres' 9
Next:Judge blocks Biden administration from enforcing new gun sales background check rule in Texas
You may also like
- Devout Christian doctor, 68, who punched dementia
- A glimpse of lotus flowers in China
- View of tea garden in China's Hubei
- How Will Xi's Visit to Xiong'an Reshape the Future of the Futuristic City?
- Jon Wysocki dead at 53: Staind drummer passes away
- Xi Focus: Xi's Inspiring Words for Young People
- Autumn scenery in Changqing scenic area, Hebei
- Xi Replies to Letter from Students, Calling for Greater Contributions to Rural Revitalization
- Climber found dead on Denali, North America's tallest peak